tm logo

Monitor this mark

View On USPTO

OUTLOOK THERAPEUTICS
Live/Pending
SECOND EXTENSION - GRANTED

granted

on 28 Jun 2024

Last Applicant/ Owned by

Outlook Therapeutics, Inc.

485 Route 1 South, Building F, Suite 320

Iselin

NJ

08830

Serial Number

97478024 filed on 27th Jun 2022

Registration Number

N/A

Correspondent Address

Ariana Hiscott

Ariana Hiscott COOLEY LLP

WASHINGTON, DC 20004

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

OUTLOOK THERAPEUTICS

Pharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceuticals, namely, ophthalmic drugs for the treatment of retinal disease

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97478024

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 325849-20000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
23rd Dec 2024SOU TEAS EXTENSION RECEIVED
28th Jun 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
28th Jun 2024SOU EXTENSION 2 FILED
28th Jun 2024SOU TEAS EXTENSION RECEIVED
28th Jun 2024SOU EXTENSION 2 GRANTED
11th Jan 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09th Jan 2024SOU EXTENSION 1 GRANTED
09th Jan 2024SOU EXTENSION 1 FILED
09th Jan 2024SOU TEAS EXTENSION RECEIVED
11th Jul 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT